HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Kawagoe Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

1/2012Ezetimibe reduces urinary albumin excretion in hypercholesterolaemic type 2 diabetes patients with microalbuminuria.
11/2008Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Kawagoe Research Topics

Disease

2Diabetic Nephropathies (Diabetic Nephropathy)
01/2012 - 11/2008
2Ischemia
11/2008 - 06/2004
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2006 - 06/2004
1Birth Weight (Birth Weights)
06/2016
1Intellectual Disability (Idiocy)
06/2016
1Cerebral Palsy (Spastic Diplegia)
06/2016
1Fetal Growth Retardation (Intrauterine Growth Retardation)
06/2016
1Type 2 Diabetes Mellitus (MODY)
01/2012
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2006
1Hyperlipidemias (Hyperlipidemia)
06/2004
1Hypesthesia (Numbness)
06/2004
1Proteinuria
06/2004
1Skin Ulcer
06/2004
1Arteriosclerosis Obliterans
06/2004
1Hypoalbuminemia
06/2004
1Pain (Aches)
06/2004
1Hypoxia (Hypoxemia)
07/2001
1Acidosis
07/2001
1Embolism (Embolus)
06/2001
1Collagen Diseases (Collagen Disease)
06/2001
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2001
1Lung Diseases (Lung Disease)
06/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2000
1Refractory Anemia
04/2000
1Refractory Anemia with Excess of Blasts (RAEM)
04/2000

Drug/Important Bio-Agent (IBA)

3oxidized low density lipoproteinIBA
01/2012 - 06/2004
2CreatinineIBA
01/2012 - 06/2004
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2006 - 06/2004
1Neuroprotective AgentsIBA
06/2016
1SteroidsIBA
06/2016
1MagnesiumIBA
06/2016
1Ezetimibe (Zetia)FDA Link
01/2012
1CholesterolIBA
01/2012
1AlbuminsIBA
01/2012
1azelnidipineIBA
11/2008
1AntioxidantsIBA
11/2008
1Angiotensin Receptor AntagonistsIBA
11/2008
1Pharmaceutical PreparationsIBA
01/2006
1Fatty Acid-Binding ProteinsIBA
01/2006
1Proteins (Proteins, Gene)FDA Link
06/2004
1Hormones (Hormone)IBA
07/2001
1Glucagon (Glukagon)FDA Link
07/2001
1Insulin (Novolin)FDA Link
07/2001
1Blood Glucose (Blood Sugar)IBA
07/2001
1Glucose (Dextrose)FDA LinkGeneric
07/2001
1Oxygen (Dioxygen)IBA
06/2001
1AclarubicinIBA
04/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2000
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2000

Therapy/Procedure

2Blood Component Removal (Apheresis)
01/2006 - 06/2004
1Therapeutics
11/2008
1CAG protocol
04/2000